288330 — Parataxis Korea Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Parataxis Korea, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,924	3,024	100	2.18	9
Cost of Revenue
Gross Profit	758	—	33.3	2.18	3
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	28,316	46,525	40,449	19,532	26,895
Operating Profit	-26,392	-43,501	-40,349	-19,530	-26,886
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-26,278	-41,700	-42,455	-19,933	-32,773
Provision for Income Taxes
Net Income After Taxes	-26,278	-41,700	-42,455	-19,933	-32,240
Minority Interest
Net Income Before Extraordinary Items
Net Income	-26,278	-41,700	-42,321	-19,756	-30,995
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-26,278	-41,700	-42,321	-19,756	-30,995
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-947	-1,479	-1,449	-472	-346
Dividends per Share